Inventor · disambiguated record
Marc Labelle
Also filed as: LABELLE MARC · LABELLE MARC A
42 granted patents·16 pending applications·1,027 citations·filing 1991–2024
98Inventor score
Files withMERCK FROSST CANADA INC17AMGEN INC9NMD PHARMA AS6GILEAD SCIENCES INC4Inthera Bioscience AG4
Top patents by PatentIndex Score
58 records- 0197US5565473AUnsaturated hydroxyalkylquinoline acids as leukotriene antagonistsMERCK FROSST CANADA INC·Filed 1995·Granted Oct 15, 1996·156 cites·23 claims
- 0296US5532237AIndole derivatives with affinity for the cannabinoid receptorMERCK FROSST CANADA INC·Filed 1995·Granted Jul 2, 1996·223 cites·5 claims
- 0393US7199119B2Antiinflammation agentsAMGEN INC·Filed 2003·Granted Apr 3, 2007·75 cites·11 claims
- 0491US6410583B1Cyclopentanoindoles, compositions containing such compounds and methods of treatmentMERCK FROSST CANADA INC·Filed 2001·Granted Jun 25, 2002·63 cites·15 claims
- 0586US7635695B2Antiinflammation agentsAMGEN INC·Filed 2007·Granted Dec 22, 2009·10 cites·20 claims
- 0685US6242493B1Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatmentMERCK FROSST CANADA INC·Filed 1999·Granted Jun 5, 2001·41 cites·16 claims
- 0785US5270324AFluorinated hydroxyalkylquinoline acids as leukotriene antagonistsMERCK FROSST CANADA INC·Filed 1992·Granted Dec 14, 1993·54 cites·9 claims
- 0885US5266568AHydroxyalkylquinoline ether acids as leukotriene antagonistsMERCK FROSST CANADA INC·Filed 1991·Granted Nov 30, 1993·29 cites·19 claims
- 0984US6211197B1Prostaglandin receptor ligandsMERCK FROSST CANADA INC·Filed 1999·Granted Apr 3, 2001·61 cites·12 claims
- 1084US5856322AUnsaturated hydroxyalkylquinoline acids as leukotriene antagonistsMERCK FROSST CANADA INC·Filed 1996·Granted Jan 5, 1999·36 cites·18 claims
- 1183US7244727B2Fused bicyclic nitrogen-containing heterocyclesJAPAN TOBACCO INC·Filed 2003·Granted Jul 17, 2007·22 cites·57 claims
- 1281US6846834B2Antiinflammation agentsAMGEN INC·Filed 2001·Granted Jan 25, 2005·15 cites·73 claims
- 1381US6436965B1PDE IV inhibiting amides, compositions and methods of treatmentMERCK FROSST CANADA INC·Filed 2001·Granted Aug 20, 2002·17 cites·17 claims
- 1480US10710975B2Oxopiperazine derivativesInthera Bioscience AG·Filed 2018·Granted Jul 14, 2020·2 cites·18 claims
- 1580US6369084B1Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatmentMERCK FROSST CANADA INC·Filed 2000·Granted Apr 9, 2002·15 cites·21 claims
- 1679US11591284B2Compounds for the treatment of neuromuscular disordersNMD PHARMA AS·Filed 2017·Granted Feb 28, 2023·2 cites·20 claims
- 1779US7186841B2Antiinflammation agentsSYNTEX LLC·Filed 2004·Granted Mar 6, 2007·11 cites·4 claims
- 1879US5428033ASaturated hydroxyalkylquinoline acids as leukotriene antagonistsMERCK FROSST CANADA INC·Filed 1991·Granted Jun 27, 1995·42 cites·17 claims
- 1978US11730714B2Compounds for the treatment of neuromuscular disordersNMD PHARMA AS·Filed 2018·Granted Aug 22, 2023·2 cites·20 claims
- 2078US7402704B2Arylsulfones and uses related theretoAMGEN INC·Filed 2005·Granted Jul 22, 2008·3 cites·18 claims
- 2178US6369082B1Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatmentMERCK FROSST CANADA INC·Filed 2000·Granted Apr 9, 2002·12 cites·23 claims
- 2277US11306068B2Oxopiperazine derivativesInthera Bioscience AG·Filed 2020·Granted Apr 19, 2022·1 cites·20 claims
- 2377US10934244B2Compounds for use in treating neuromuscular disordersNMD PHARMA AS·Filed 2016·Granted Mar 2, 2021·4 cites·28 claims
- 2476US2025115571A1Oxopiperazine derivativesInthera Bioscience AG·Filed 2024·Application pending·0 cites
- 2574US9221801B2Inhibitors of histone demethylasesEPITHERAPEUTICS APS·Filed 2014·Granted Dec 29, 2015·5 cites·23 claims
- 2672US9650339B2Inhibitors of histone demethylasesGILEAD SCIENCES INC·Filed 2014·Granted May 16, 2017·2 cites·28 claims
- 2770US11147788B2Compounds for the treatment of neuromuscular disordersNMD PHARMA AS·Filed 2017·Granted Oct 19, 2021·2 cites·16 claims
- 2870US6586457B2Methods for inhibiting bone resorptionMERCK & CO INC·Filed 2001·Granted Jul 1, 2003·8 cites·5 claims
- 2969US6627656B2Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful thereforeFiled 2001·Granted Sep 30, 2003·5 cites·5 claims
- 3068US12012393B2Oxopiperazine derivativesInthera Bioscience AG·Filed 2022·Granted Jun 18, 2024·0 cites·18 claims
- 3166US5834228AMethod for identifying inhibitors for apopain based upon the crystal structure of the apopain: Ac-DEVD-CHO complexMERCK & CO INC·Filed 1997·Granted Nov 10, 1998·38 cites·8 claims
- 3265US8426358B2Methods for treating atherosclerosisKAYSER FRANK·Filed 2011·Granted Apr 23, 2013·1 cites·6 claims
- 3365US5472964ADiaryl 5,6-fused heterocyclic acids as leukotriene antagonistsMERCK FROSST CANADA INC·Filed 1994·Granted Dec 5, 1995·20 cites·6 claims
- 3464US2023139731A1Process for preparing mannose derivativesENTEROME·Filed 2022·Application pending·0 cites
- 3563US5798442APeptidyl derivatives as inhibitors of pro-apoptotic cysteine proteinasesMERCK FROSST CANADA INC·Filed 1995·Granted Aug 25, 1998·25 cites·3 claims
- 3660US11560399B2Process for preparing mannose derivativesENTEROME·Filed 2019·Granted Jan 24, 2023·0 cites·19 claims
- 3758US10189787B2Inhibitors of histone demethylasesGILEAD SCIENCES INC·Filed 2014·Granted Jan 29, 2019·0 cites·8 claims
- 3858US7754890B2Arylsulfones and uses related theretoAMGEN INC·Filed 2008·Granted Jul 13, 2010·0 cites·11 claims
- 3958US2008096900A1Methods for treating atherosclerosisAMGEN INC·Filed 2007·Application pending·0 cites
- 4057US2007135464A1Antiinflammation agentsAMGEN INC·Filed 2007·Application pending·0 cites
- 4154US2013273024A1Methods for treating atherosclerosisAMGEN INC·Filed 2013·Application pending·0 cites
- 4252US10221139B2Inhibitors of histone demethylasesGILEAD SCIENCES INC·Filed 2017·Granted Mar 5, 2019·0 cites·13 claims
- 4352US6414006B1Methods for inhibiting bone resorptionMERCK FROSST CANADA INC·Filed 1999·Granted Jul 2, 2002·12 cites·13 claims
- 4452US2007244096A1Fused Bicyclic Nitrogen-Containing HeterocyclesJAPAN TOBACCO INC·Filed 2007·Application pending·0 cites
- 4551US2002004495A1Methods for stimulating bone formationFiled 2001·Application pending·0 cites
- 4649US5750539AHeteroaryl diol acids as leukotriene antagonistsMERCK FROSST CANADA·Filed 1995·Granted May 12, 1998·9 cites·8 claims
- 4749US2015203453A1Inhibitors of histone demethylasesEPITHERAPEUTICS APS·Filed 2013·Application pending·0 cites
- 4845US2003130333A1Combination product and methods of useFiled 2002·Application pending·0 cites
- 4945US2022274938A15-[(1s)-1-(4-bromophenoxy)ethyl]-2h-tetrazole derivatives and related compounds as clc-1 ion channel inhibitors for treating neuromuscular disordersNMD PHARMA AS·Filed 2020·Application pending·0 cites
- 5044US2001031766A1Prostaglandin receptor ligandsMERCK FROSST CANADA INC·Filed 2001·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Marc Labelle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →